Matrix metalloproteinases produced by rat IL-2-activated NK cells

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4248-4253

  Kitson, Richard P ^a,b,d   Appasamy, Pierette M ^a,b   Nannmark, Ulf ^c   Albertsson, Per ^c   Gabauer, Megan K ^a   Goldfarb, Ronald H ^a,b,d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Hlth Science Center at Forth Worth   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 2; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EXTRACELLULAR MATRIX; IMMUNOBLOTTING; MALE; METASTASIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; COLLAGENASES; GELATINASES; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 0032080375     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Goldfarb, R. H., T. L. Whiteside, P. H. Basse, W. C. Lin, N. Vujanovic, and R. B. Herberman. 1994. Natural killer cells and gene therapy: potential of gene transfection tor optimizing effector cell functions and for targeting gene products into tumor metastases. Nat. Immun. 13:131.
2. Goldfarb, R. H., and K. W. Brunson. 1995. Antimetastatic therapy. In Biological Therapy of Cancer, 2nd Ed. V. T. J. DeVita, S. Hellman, and S. A. Rosenberg, eds. J. B. Lippincott, Philadelphia, p. 853.
3. Goldfarb, R. H., R. P. Kitson, and K. W. Brunson. 1996. Biology of cancer metastases. In Regional Therapy of Advanced Cancer. M. T. Lotze and J. T. Rubin, eds. Lippincott-Raven, Philadelphia, p. 1.
4. Goldfarb, R. H., P. H. Basse, M. Ohashi, R. P. Kitson, and K. W. Brunson. 1994. Preclinical studies of IL-2 activated natural killer effector cells for locoregional therapy of metastatic cancer. J. Infus. Chemother. 4:77.
5. Basse, P., R. B. Herberman, U. Nannmark, B. R. Johansson, M. Hokland, K. Wasserman, and R. H. Goldfarb. 1991. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in mutine metastases. J. Exp. Med. 174:479.
6. Basse, P. H., U. Nannmark, B. R. Johansson, R. B. Herberman, and R. H. Goldfarb. 1991. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J.Nat. Cancer Inst. 83:944.
7. Basse, P. H., and R. H. Goldfarb. 1994. Localization of immune effector cells to tumor metastases. In Tumor Immunology and Cancer Therapy. R. H. Goldfarb and T. L. Whiteside,eds. Marcel Dekker, Inc., New York, p. 149.
8. Basse, P. H., R. B. Herberman,M. E. Hokland, and R. H. Goldfarb. 1992. Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration. Nat. Immun. 11:193.
9. Basse, P., R. B. Herberman, M. Hokland, and R. H. Goldfarb. 1992. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer Immunol. Immunother. 34:221.
10. Basse, P. H., R. H. Goldfarb, R. B. Herberman, and M. E. Hokland. 1994. Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. In Vivo 8:17.
11. Kuppen, P. J., P. H. Basse, R. H. Goldfarb, C. J. Van De Velde, G. J. Fleuren, and A. M. Eggermont. 1994. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats. Int. J. Cancer 56:574.
12. Nannmark, U., B. R. Johansson, J. L. Bryant, M. L. Unger, M. E. Hokland, R. H. Goldfarb, and P. H. Basse. 1995. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Res. 55:4627.
13. Goldfarb, R. H. 1997. NK cells: adhesive interactions, microvasculature, extracellular matrices and angiogenesis: preface. Nat. Immun. 15:75.
14. Johansson, B. R., and U. Nannmark. 1996. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment. Nat. Immun. 15:98.
15. Zeng, L., S. An, and E. J. Goetzl. 1996. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Biochemistry 35:7159.
16. Whiteside, T. L., and R. H. Goldfarb. 1994. Antitumor effector cells: extravasation and control of metastasis. In Tumor Immunology and Cancer Therapy. R. H. Goldfarb and T. L. Whiteside, eds. Marcel Dekker, Inc., New York, p. 159.
17. Allavena, P., G. Blanchi, C. Paganin, G. Giardina, and A. Mantovani. 1996. Regulation of adhesion and transendothelial migration of natural killer cells. Nat. Immun. 15:107.
18. Fogler, W. E., K. Volker, K. L. McCormick, M. Watanabe, J. R. Ortaldo, and R. H. Wiltrout. 1996. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707.
19. Hagmann, W. K., M. W. Lark, and J. W. Becker. 1996. Inhibition of matrix metalloproteinases. Annu. Rep. Med. Chem. 34:231.
20. Ennis, B. W., and L. M. Matrisian. 1994. Matrix degrading metalloproteinases. In Brain Tumor Invasiveness. R. H. Goldfarb, ed. Kluwer, Dordrecht, p. 17.
21. Goldfarb, R. H., G. Murano, R. Brundage, G. P. Siegal, V. Terranova, S. Garbisa, and L. A. Liotta. 1986. Degradation of glycoprotein and collagenous components of the basement membrane: studies with urokinase-type plasminogen activator, alpha-thrombin, and plasmin. Semin. Thromb. Hemost. 12:335.
22. Goldfarb, R. H., T. Timonen, and R. B. Herberman. 1984. Production of plasminogen activator by human natural killer cells: large granular lymphocytes. J. Exp. Med. 159:935.
23. Goldfarb, R. H., K. Wasserman, R. B. Herberman, and R. P. Kitson. 1992. Non-granular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role. J. Immunol. 149:2061.
24. Wasserman, K., R. P. Kitson, A. J. Rivett, S. T. Sweeney, M. K. Gabauer, R. B. Herberman, S. C. Watkins, and R H. Goldfarb. 1994. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex. J. Cell. Biochem. 55:133.
25. Wasserman, K., R. P. Kitson, M. K. Gabauer, C. A. Miller, R. B. Herberman, and R. H. Goldfarb. 1994. Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells. In Vivo 8:33.
26. Goldfarb, R. H., and J. P. Quigley. 1978. Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts. Cancer Res. 38:4601.
27. Goldfarb, R. H., and J. P. Quigley. 1980. Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo tibroblasts treated with the tumor promoter phorbol 12-myrislate 13-acetate. Biochemistry 19:5463.
28. Welch, W. C., R. S. Morrison, J. L. Gross, S. M. Gollin, R. B. Kitson, R. H. Goldfarb, K. A. Giuliano, M. K. Bradley, and P. L. Komblith. 1995. Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19. In Vitro Cell. Dev. Biol. Anim. 31:610.
29. Goldfarb, R. H., and L. A. Liotta. 1986. Proteolytic enzymes in cancer invasion and metastasis. Semin. Thromb. Hemost. 12:294.
30. Liotta, L. A., R. H. Goldfarb, R. Brundage, G. P. Siegal, V. Terranova, and S. Garbisa. 1981. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41:4629.
31. Leppert, D., E. Waubant, R. Galardy, N. W. Bunnett, and S. L. Hauser. 1995. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:4379.
32. Romanic, A. M., and J. A. Madri. 1994. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125:1165.
33. Vujanovic, N. L., R. B. Herberman, A. Al Maghazachi, and J. C. Hiserodt. 1988. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J. Exp. Med. 167:15.
34. Chambers, W. H., N. L. Vujanovic, A. B. DeLeo, M. W. Olszowy, R. B. Herberman, and J. C. Hiserodt. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169:1373.
35. Giorda, R., W. A. Rudert, C. Vavassori, W. H. Chambers, J. C. Hiserodt, and M. Trucco. 1990. NKR-P1, a signal transduction molecule on natural killer cells. Science 249:1298.
36. Thomas, C., A. M. Nijenhuis, W. Timens, P. J. Kuppen, T. Daemen, and G. L. Scherphof. 1993. Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13:102.
37. Mackay, A. R., R. H. Corbitt, J. L. Hartzler, and U. P. Thorgeirsson. 1990. Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metallopioteinases. Cancer Res. 50:5997.
38. Zhou, H., E. J. Bernhard, F. E. Fox, and P. C. Billings. 1993. Induction of metalloproteinase activity in human T-lymphocytes. Biochim. Biophys. Acta 1177:174.
39. Mackay, A. R., J. L. Kanzler, M. D. Pelina, and U. P. Thorgeirsson. 1990. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J. Biol. Chem. 265:21929.
40. Xie, B., Z. Dong, and I. J. Fidler. 1994. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152:3637.
41. Harper, J. W., K. Hemmi, and J. C. Powers. 1985. Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor. Biochemistry 24:1831.
42. Fisher, C., B. S. Gilbertson, E. A. Powers, G. Petzold, R. Poorman, and M. A. Mitchell. 1994. Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol. 162:499.
43. Leppert, D., S. L. Hauser, J. L. Kishiyama, S. An, L. Zeng, and E. J. Goetzl. 1995. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB J. 9:1473.
44. Montgomery, A. M., H. Sabzevari, and R. A. Reisfeld. 1993. Production and regulation of gelatinase B by human T-cells. Biochim. Biophys. Acta 1176:265.
45. Weeks, B. S., H. W. Schnaper, M. Handy, E. Holloway, and H. K. Kleinman. 1993. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J. Cell Physiol. 157:644.
46. Xia, M., D. Leppert, S. L. Hauser, S. P. Sreedharan, P. J. Nelson, A. M. Krensky, and E. J. Goetzl. 1996. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol. 156:160.
47. Conca, W., and F. Willmroth. 1994. Human T lymphocytes express a member of the matrix metalloproteinase gene family. Arthritis Rheum. 37:951.
48. Johnatty, R. N., D. D. Taub, S. P. Reeder, S. M. Turcovskicorrales, D. W. Cottam, T. J. Stephenson, and R. C. Rees. 1997. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J. Immunol. 158:2327.
49. Gunderson, D., C. Tran-Thang, B. Sordat, F. Mourali, and C. Rüegg. 1997. Plasmin-induced proteolysis of tenacin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J. Immunol. 158:1051.
50. Watson, S. A., T. M. Morris, G. Robinson, M. J. Crimmin, P. D. Brown, and J. D. Hardcastle. 1995. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res. 55:3629.
51. Wang, X., X. Fu, P. D. Brown, M. J. Crimmin, and R. M. Hoffman. 1994. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 54:4726.
52. Davies, B., P. D. Brown, N. East, M. J. Crimmin, and F. R. Balkwill. 1993. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53:2087.